Exploring the potential of a polyvinyl alcohol/chitosan-based nanofibrous matrix for erythromycin delivery: fabrication,<i>in vitro</i>and<i>in vivo</i>evaluation
Yuan Cheng, Bahareh Farasati Far, Mehdi Jahanbakhshi, Shima Bahrami, Pegah Tamimi, Meysam Sedaghat, Elham Ghazizadeha
Abstract
drug release and biocompatibility compared to the free drug. The study provides important insights into the potential of polyvinyl alcohol/chitosan nanofibers as a drug delivery system for erythromycin and highlights the need for further investigation into the development of nanofibrous drug delivery systems based on polyvinyl alcohol/chitosan for improved therapeutic efficacy and reduced toxicity. The nanofibers prepared in this approach use less antibiotics, which may be beneficial to the environment. The resulting nanofibrous matrix can be used for external drug delivery applications, such as wound healing or topical antibiotic therapy.